"Calgary, Alberta--(Newsfile Corp. - October 25, 2023) - Zenith Epigenetics Ltd. ("Zenith" or the "Company"), a global leader in epigenetics, announced today it has entered into an agreement with Cencora (formerly AmerisourceBergen) aimed at accelerating the commercialization of Zenith Epigenetics' ZEN-3694 program. "
The agreement between Zenith and Cencora sounds similar to the partnership between Resverlogix and EVERSANA.
"The company will utilize EVERSANA’s fully integrated commercialization services, including compliance and clinical and commercial field teams"
Koo
